APA (7th ed.) Citation

KSP, K., MN, J., & A, P. (2025). CHD1 dysregulation in cancer: Bridging chromatin instability, therapy resistance, and immune evasion. Molecular biology reports, 52(1), 426. https://doi.org/10.1007/s11033-025-10536-w

Chicago Style (17th ed.) Citation

KSP, Kumar, Jyothi MN, and Prashant A. "CHD1 Dysregulation in Cancer: Bridging Chromatin Instability, Therapy Resistance, and Immune Evasion." Molecular Biology Reports 52, no. 1 (2025): 426. https://doi.org/10.1007/s11033-025-10536-w.

MLA (9th ed.) Citation

KSP, Kumar, et al. "CHD1 Dysregulation in Cancer: Bridging Chromatin Instability, Therapy Resistance, and Immune Evasion." Molecular Biology Reports, vol. 52, no. 1, 2025, p. 426, https://doi.org/10.1007/s11033-025-10536-w.